{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:10:53Z","timestamp":1790223053023,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08666-w","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T05:02:50Z","timestamp":1738126970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate"],"prefix":"10.1186","volume":"26","author":[{"given":"Laetitia","family":"Clotaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rubera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Duranton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chamorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Humeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Yamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chiaverini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Willoteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Mourozeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mainguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Baillif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Leftheriotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"8666_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1477-7525-9-113","volume":"9","author":"RP Finger","year":"2011","unstructured":"Finger RP, Fenwick E, Marella M, Charbel Issa P, Scholl HPN, Holz FG, et al. The relative impact of vision impairment and cardiovascular disease on quality of life: the example of pseudoxanthoma elasticum. Health Qual Life Outcomes. 2011;9:113.","journal-title":"Health Qual Life Outcomes"},{"key":"8666_CR2","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jvs.2011.04.041","volume":"54","author":"G Leftheriotis","year":"2011","unstructured":"Leftheriotis G, Abraham P, Le Corre Y, Le Saux O, Henrion D, Ducluzeau PH, et al. Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum. J Vasc Surg. 2011;54:1390\u20134.","journal-title":"J Vasc Surg"},{"key":"8666_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000016076","volume":"10","author":"JS van den Berg","year":"2000","unstructured":"van den Berg JS, Hennekam RC, Cruysberg JR, Steijlen PM, Swart J, Tijmes N, et al. Prevalence of symptomatic intracranial aneurysm and ischaemic stroke in pseudoxanthoma elasticum. Cerebrovasc Dis. 2000;10:315\u20139.","journal-title":"Cerebrovasc Dis"},{"key":"8666_CR4","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1161\/ATVBAHA.113.301901","volume":"33","author":"L Campens","year":"2013","unstructured":"Campens L, Vanakker OM, Trachet B, Segers P, Leroy BP, De Zaeytijd J, et al. Characterization of cardiovascular involvement in pseudoxanthoma elasticum families. Arterioscler Thromb Vasc Biol. 2013;33:2646\u201352.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"8666_CR5","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1681\/ASN.2017101148","volume":"29","author":"E Letavernier","year":"2018","unstructured":"Letavernier E, Kauffenstein G, Huguet L, Navasiolava N, Bouderlique E, Tang E, et al. ABCC6 deficiency promotes development of Randall plaque. J Am Soc Nephrol. 2018;29:2337\u201347.","journal-title":"J Am Soc Nephrol"},{"key":"8666_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ajmg.a.33162","volume":"152A","author":"G Le Boulanger","year":"2010","unstructured":"Le Boulanger G, Labreze C, Croue A, Schurgers LJ, Chassaing N, Wittkampf T, et al. An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am J Med Genet A. 2010;152A:118\u201323.","journal-title":"Am J Med Genet A"},{"key":"8666_CR7","doi-asserted-by":"crossref","first-page":"20206","DOI":"10.1073\/pnas.1319582110","volume":"110","author":"RS Jansen","year":"2013","unstructured":"Jansen RS, K\u00fc\u00e7\u00fckosmano\u011flu A, De Haas M, Sapthu S, Otero JA, Hegman IEM, et al. ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Natl Acad Sci USA. 2013;110:20206\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8666_CR8","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.3390\/jcm11092588","volume":"11","author":"G Leftheriotis","year":"2022","unstructured":"Leftheriotis G, Navasiolava N, Clotaire L, Duranton C, Le Saux O, Bendahhou S, et al. Relationships between plasma pyrophosphate, vascular calcification and clinical severity in patients affected by pseudoxanthoma elasticum. JCM. 2022;11:2588.","journal-title":"JCM"},{"key":"8666_CR9","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3390\/jcm12051893","volume":"12","author":"M Van Gils","year":"2023","unstructured":"Van Gils M, Depauw J, Coucke PJ, Aerts S, Verschuere S, Nollet L, et al. Inorganic pyrophosphate plasma levels are decreased in pseudoxanthoma elasticum patients and heterozygous carriers but do not correlate with the genotype or phenotype. JCM. 2023;12:1893.","journal-title":"JCM"},{"key":"8666_CR10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/jcm10010114","volume":"10","author":"H Luo","year":"2020","unstructured":"Luo H, Li Q, Cao Y, Uitto J. Therapeutics development for pseudoxanthoma elasticum and related ectopic mineralization disorders: update 2020. JCM. 2020;10:114.","journal-title":"JCM"},{"key":"8666_CR11","doi-asserted-by":"crossref","unstructured":"Finger RP, Issa PC, Schmitz-Valckenberg S, Holz FG, Scholl HN. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Retina. 2011;31:1268\u201378. https:\/\/journals.lww.com\/00006982-201107000-00006","DOI":"10.1097\/IAE.0b013e318207d1dc"},{"key":"8666_CR12","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.3390\/ijms20246353","volume":"20","author":"E Letavernier","year":"2019","unstructured":"Letavernier E, Bouderlique E, Zaworski J, Martin L, Daudon M. Pseudoxanthoma elasticum, kidney stones and pyrophosphate: from a rare disease to urolithiasis and vascular calcifications. IJMS. 2019;20:6353.","journal-title":"IJMS"},{"key":"8666_CR13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/bjd.18632","volume":"183","author":"L Omarjee","year":"2020","unstructured":"Omarjee L, Nitschke Y, Verschuere S, Bourrat E, Vignon M-D, Navasiolava N, et al. Severe early-onset manifestations of pseudoxanthoma elasticum resulting from the cumulative effects of several deleterious mutations in ENPP1, ABCC6 and HBB\u202f: transient improvement in ectopic calcification with sodium thiosulfate. Br J Dermatol. 2020;183:367\u201372.","journal-title":"Br J Dermatol"},{"key":"8666_CR14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jaad.2019.02.055","volume":"81","author":"S Rose","year":"2019","unstructured":"Rose S, On SJ, Fuchs W, Chen C, Phelps R, Kornreich D, et al. Magnesium supplementation in the treatment of pseudoxanthoma elasticum: a randomized trial. J Am Acad Dermatol. 2019;81:263\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"8666_CR15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaad.2010.05.023","volume":"65","author":"JY Yoo","year":"2011","unstructured":"Yoo JY, Blum RR, Singer GK, Stern DK, Emanuel PO, Fuchs W, et al. A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol. 2011;65:341\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"8666_CR16","doi-asserted-by":"crossref","unstructured":"Kranenburg G, De Jong PA, Bartstra JW, Lagerweij SJ, Lam MG, Ossewaarde-van Norel J, et al. Etidronate for prevention of ectopic mineralization in patients with pseudoxanthoma elasticum. Journal of the American College of Cardiology. 2018;71:1117\u201326. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718301207","DOI":"10.1016\/j.jacc.2017.12.062"},{"key":"8666_CR17","doi-asserted-by":"crossref","unstructured":"Bartstra JW, De Jong PA, Kranenburg G, Wolterink JM, Isgum I, Wijsman A, et al. Etidronate halts systemic arterial calcification in pseudoxanthoma elasticum. Atherosclerosis. 2020;292:37\u201341. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019315229","DOI":"10.1016\/j.atherosclerosis.2019.10.004"},{"key":"8666_CR18","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.3390\/ijms24054899","volume":"24","author":"B Murcia Casas","year":"2023","unstructured":"Murcia Casas B, Carrillo Linares JL, Baquero Aranda I, Rioja Villodres J, Merino Boh\u00f3rquez V, Gonz\u00e1lez Jim\u00e9nez A, et al. Lansoprazole increases inorganic pyrophosphate in patients with pseudoxanthoma elasticum: a double-blind, randomized, placebo-controlled crossover trial. IJMS. 2023;24:4899.","journal-title":"IJMS"},{"key":"8666_CR19","doi-asserted-by":"crossref","unstructured":"Pomozi V, Brampton C, Van De Wetering K, Zoll J, Calio B, Pham K, et al. Pyrophosphate supplementation prevents chronic and acute calcification in ABCC6-deficient mice. The American Journal of Pathology. 2017;187:1258\u201372. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5455066\/","DOI":"10.1016\/j.ajpath.2017.02.009"},{"key":"8666_CR20","doi-asserted-by":"publisher","unstructured":"Dedinszki D, Szeri F, Koz\u00e1k E, Pomozi V, T\u0151k\u00e9si N, Mezei TR, et al. Oral administration of pyrophosphate inhibits connective tissue calcification. EMBO Mol Med. 2017;9:1463\u201370. https:\/\/www.embopress.org\/doi\/https:\/\/doi.org\/10.15252\/emmm.201707532","DOI":"10.15252\/emmm.201707532"},{"key":"8666_CR21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jid.2018.10.040","volume":"139","author":"V Pomozi","year":"2019","unstructured":"Pomozi V, Julian CB, Zoll J, Pham K, Kuo S, T\u0151k\u00e9si N, et al. Dietary pyrophosphate modulates calcification in a mouse model of pseudoxanthoma elasticum: implication for treatment of patients. J Investig Dermatol. 2019;139:1082\u20138.","journal-title":"J Investig Dermatol"},{"key":"8666_CR22","doi-asserted-by":"publisher","unstructured":"Barreto FC, De Oliveira RB, Benchitrit J, Louvet L, Rezg R, Poirot S, et al. Effects of pyrophosphate delivery in a peritoneal dialysis solution on bone tissue of apolipoprotein-E knockout mice with chronic kidney disease. J Bone Miner Metab. 2014;32:636\u201344. http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00774-013-0541-y","DOI":"10.1007\/s00774-013-0541-y"},{"key":"8666_CR23","doi-asserted-by":"crossref","unstructured":"Li Q, Sundberg JP, Levine MA, Terry SF, Uitto J. The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene. Cell Cycle. 2015;:0.","DOI":"10.1080\/15384101.2015.1007809"},{"key":"8666_CR24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2017.12.062","volume":"71","author":"G Kranenburg","year":"2018","unstructured":"Kranenburg G, de Jong PA, Bartstra JW, Lagerweij SJ, Lam MG, Ossewaarde-van Norel J, et al. Etidronate for prevention of ectopic mineralization in patients with pseudoxanthoma elasticum. J Am Coll Cardiol. 2018;71:1117\u201326.","journal-title":"J Am Coll Cardiol"},{"key":"8666_CR25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/21678707.2014.908702","volume":"2","author":"J Uitto","year":"2014","unstructured":"Uitto J, Jiang Q, V\u00e1radi A, Bercovitch LG, Terry SF. Pseudoxanthoma elasticum: diagnostic features, classification and treatment options. Expert Opin Orphan Drugs. 2014;2:567\u201377.","journal-title":"Expert Opin Orphan Drugs"},{"key":"8666_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989;10:1\u201310.","journal-title":"Control Clin Trials"},{"key":"8666_CR27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejvs.2013.11.010","volume":"47","author":"P Abraham","year":"2014","unstructured":"Abraham P, Godet R, Harbonnier M, Laneelle D, Leftheriotis G, Ouedraogo N. External validation of the \u201cWalking Estimated Limitation Calculated by History\u201d (WELCH) Questionnaire in patients with claudication. Eur J Vasc Endovasc Surg. 2014;47:319\u201325.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"8666_CR28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.semvascsurg.2014.01.002","volume":"26","author":"SH Ko","year":"2013","unstructured":"Ko SH, Bandyk DF. Interpretation and significance of ankle-brachial systolic pressure index. Semin Vasc Surg. 2013;26:86\u201394.","journal-title":"Semin Vasc Surg"},{"key":"8666_CR29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jvs.2009.01.042","volume":"50","author":"SPA Nicola\u00ef","year":"2009","unstructured":"Nicola\u00ef SPA, Viechtbauer W, Kruidenier LM, Candel MJJM, Prins MH, Teijink JAW. Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis. J Vasc Surg. 2009;50:322\u20139.","journal-title":"J Vasc Surg"},{"key":"8666_CR30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0895-4356(98)00093-6","volume":"51","author":"A Lepl\u00e8ge","year":"1998","unstructured":"Lepl\u00e8ge A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey. J Clin Epidemiol. 1998;51:1013\u201323.","journal-title":"J Clin Epidemiol"},{"key":"8666_CR31","doi-asserted-by":"crossref","unstructured":"Laurain A, Rubera I, Duranton C, Rutsch F, Nitschke Y, Ray E, et al. Alkaline phosphatases account for low plasma levels of inorganic pyrophosphate in chronic kidney disease. Front Cell Dev Biol. 2020;8:586831. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7793922\/","DOI":"10.3389\/fcell.2020.586831"},{"key":"8666_CR32","doi-asserted-by":"publisher","unstructured":"Chan A-W, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346 jan08 15:e7586\u2013e7586. https:\/\/www.bmj.com\/lookup\/doi\/https:\/\/doi.org\/10.1136\/bmj.e7586","DOI":"10.1136\/bmj.e7586"},{"key":"8666_CR33","doi-asserted-by":"crossref","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. Journal of the American College of Cardiology. 1990;15:827\u201332. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/073510979090282T","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"8666_CR34","doi-asserted-by":"publisher","unstructured":"Amrani S, Eveilleau K, Fassbender V, Obeid H, Abi-Nasr I, Giordana P, et al. Assessment of the systolic rise time by photoplethysmography in peripheral arterial diseases: a comparative study with ultrasound Doppler. European Heart Journal Open. 2022;2:oeac032. https:\/\/academic.oup.com\/ehjopen\/article\/doi\/https:\/\/doi.org\/10.1093\/ehjopen\/oeac032\/6575236","DOI":"10.1093\/ehjopen\/oeac032\/6575236"},{"key":"8666_CR35","doi-asserted-by":"crossref","unstructured":"Singh A, Bhari N, Bhari A. Dermoscopy of pseudoxanthoma elasticum. BMJ Case Reports. 2017;:bcr-2017\u2013221365.","DOI":"10.1136\/bcr-2017-221365"},{"key":"8666_CR36","doi-asserted-by":"crossref","unstructured":"Bouderlique E, Kervadec J, Tang E, Zaworski J, Coudert A, Rubera I, et al. Oral\u00a0pyrophosphate protects Abcc6-\/- mice against vascular calcification induced by chronic\u00a0kidney disease. J Mol Med. 2024;102:1217\u201327.","DOI":"10.1007\/s00109-024-02468-y"},{"key":"8666_CR37","doi-asserted-by":"publisher","unstructured":"Koz\u00e1k E, F\u00fcl\u00f6p K, T\u0151k\u00e9si N, Rao N, Li Q, Terry SF, et al. Oral supplementation of inorganic pyrophosphate in pseudoxanthoma elasticum. Experimental Dermatology. 2022;31:548\u201355. https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/exd.14498","DOI":"10.1111\/exd.14498"},{"key":"8666_CR38","doi-asserted-by":"crossref","unstructured":"V\u00e4\u00e4r\u00e4m\u00e4k S, Uusitalo H, T\u0151k\u00e9si N, Pelttari S, V\u00e1radi A, Nevalainen PI. Pyrophosphate treatment in pseudoxanthoma elasticum (PXE)-preventing reocclusion after surgery for critical limb ischaemia. SCR. 2019;:1\u20133. https:\/\/www.sciencerepository.org\/pyrophosphate-treatment-in-pseudoxanthoma-elasticum-pxe-preventing-re-occlusion-after-surgery-for-critical-limb-ischaemia_SCR-2019-4-102","DOI":"10.31487\/j.SCR.2019.04.02"},{"key":"8666_CR39","first-page":"1129","volume":"58","author":"R Tolouian","year":"2012","unstructured":"Tolouian R, Connery SM, O\u2019Neill WC, Gupta A. Using a filtration technique to isolate platelet free plasma for assaying pyrophosphate. Clin Lab. 2012;58:1129\u201334.","journal-title":"Clin Lab"},{"key":"8666_CR40","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.3390\/ijms25126502","volume":"25","author":"I Rubera","year":"2024","unstructured":"Rubera I, Clotaire L, Laurain A, Destere A, Martin L, Duranton C, et al. A plasma pyrophosphate cutoff value for diagnosing pseudoxanthoma elasticum. IJMS. 2024;25:6502.","journal-title":"IJMS"},{"key":"8666_CR41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/jmg.2007.051094","volume":"44","author":"EG Pfendner","year":"2007","unstructured":"Pfendner EG, Vanakker OM, Terry SF, Vourthis S, McAndrew PE, McClain MR, et al. Mutation detection in the ABCC6 gene and genotype phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J Med Genet. 2007;44:621\u20138.","journal-title":"J Med Genet"},{"key":"8666_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096003","volume":"9","author":"G Leftheriotis","year":"2014","unstructured":"Leftheriotis G, Kauffenstein G, Hamel JF, Abraham P, Le Saux O, Willoteaux S, et al. The contribution of arterial calcification to peripheral arterial disease in pseudoxanthoma elasticum. PLoS ONE. 2014;9: e96003.","journal-title":"PLoS ONE"},{"key":"8666_CR43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s13244-018-0621-6","volume":"9","author":"A Vos","year":"2018","unstructured":"Vos A, Kranenburg G, De Jong PA, Mali WPTM, Van Hecke W, Bleys RLAW, et al. The amount of calcifications in pseudoxanthoma elasticum patients is underestimated in computed tomographic imaging; a post-mortem correlation of histological and computed tomographic findings in two cases. Insights Imaging. 2018;9:493\u20138.","journal-title":"Insights Imaging"},{"key":"8666_CR44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCRESAHA.116.310326","volume":"120","author":"LL Demer","year":"2017","unstructured":"Demer LL, Tintut Y, Nguyen K-L, Hsiai T, Lee JT. Rigor and reproducibility in analysis of vascular calcification. Circ Res. 2017;120:1240\u20132.","journal-title":"Circ Res"},{"key":"8666_CR45","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3390\/jcm9051393","volume":"9","author":"A Gutierrez-Cardo","year":"2020","unstructured":"Gutierrez-Cardo A, Lillo E, Murcia-Casas B, Carrillo-Linares JL, Garc\u00eda-Arg\u00fcello F, S\u00e1nchez-S\u00e1nchez P, et al. Skin and arterial wall deposits of 18F-NaF and severity of disease in patients with pseudoxanthoma elasticum. JCM. 2020;9:1393.","journal-title":"JCM"},{"key":"8666_CR46","doi-asserted-by":"crossref","unstructured":"Mention P-J, Lacoeuille F, Leftheriotis G, Martin L, Omarjee L. 18F-Flurodeoxyglucose and 18F-sodium fluoride positron emission tomography\/computed tomography imaging of arterial and cutaneous alterations in pseudoxanthoma elasticum. Circ: Cardiovascular Imaging. 2018;11:e007060.","DOI":"10.1161\/CIRCIMAGING.117.007060"}],"updated-by":[{"DOI":"10.1186\/s13063-025-08797-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08666-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08666-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08666-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T21:05:46Z","timestamp":1743714346000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08666-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8666"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08666-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13063-025-08797-8","URL":"https:\/\/doi.org\/10.1186\/s13063-025-08797-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}